Short-Term Outcomes of Conventional Laparoscopic versus Robot-Assisted Distal Pancreatectomy for Malignancy: Evidence from US National Inpatient Sample, 2005–2018
Author:
Huang Jyun-Ming12, Chen Sheng-Hsien12, Chen Te-Hung12
Affiliation:
1. Department of Surgery, China Medical University Hospital, No. 2, Yude Rd., North Dist., Taichung City 404327, Taiwan 2. School of Medicine, China Medical University, No. 2, Yude Rd., North Dist., Taichung City 404, Taiwan
Abstract
Background: The primary treatment for pancreatic cancer is surgical resection, and laparoscopic resection offers benefits over open surgery. This study aimed to compare the short-term outcomes of robot-assisted vs. conventional laparoscopic distal pancreatectomy. Methods: Data of adults ≥ 20 years old with pancreatic cancer who underwent conventional laparoscopic or robot-assisted laparoscopic distal pancreatectomy were extracted from the United States (US) Nationwide Inpatient Sample (NIS) 2005–2018 database. Comorbidities and complications were identified through the International Classification of Diseases (ICD) codes. Short-term outcomes were compared using logistic regression and included length of hospital stay (LOS), perioperative complications, in-hospital mortality, unfavorable discharge, and total hospital costs. Results: A total of 886 patients were included; 27% received robot-assisted, and 73% received conventional laparoscopic surgery. The mean age of all patients was 65.3 years, and 52% were females. Multivariable analysis revealed that robot-assisted surgery was associated with a significantly reduced risk of perioperative complications (adjusted odds ratio (aOR) = 0.61, 95% confidence interval (CI): 0.45–0.83) compared to conventional laparoscopic surgery. Specifically, robot-assisted surgery was associated with a significantly decreased risk of VTE (aOR = 0.35, 95% CI: 0.14–0.83) and postoperative blood transfusion (aOR = 0.37, 95% CI: 0.23–0.61). Robot-assisted surgery was associated with a significantly shorter LOS (0.76 days shorter, 95% CI: −1.43–−0.09) but greater total hospital costs (18,284 USD greater, 95% CI: 4369.03–32,200.70) than conventional laparoscopic surgery. Conclusions: Despite the higher costs, robot-assisted distal pancreatectomy is associated with decreased risk of complications and shorter hospital stays than conventional laparoscopic distal pancreatectomy.
Reference30 articles.
1. Partyka, O., Pajewska, M., Kwaśniewska, D., Czerw, A., Deptała, A., Budzik, M., Cipora, E., Gąska, I., Gazdowicz, L., and Mielnik, A. (2023). Overview of Pancreatic Cancer Epidemiology in Europe and Recommendations for Screening in High-Risk Populations. Cancers, 15. 2. Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors;Rawla;World J. Oncol.,2019 3. Pancreatic cancer: A review of epidemiology, trend, and risk factors;Hu;World J. Gastroenterol.,2021 4. The actual 5-year survivors of pancreatic ductal adenocarcinoma based on real-world data;Bengtsson;Sci. Rep.,2020 5. Role of surgery in pancreatic cancer;Buanes;World J. Gastroenterol.,2017
|
|